JP2005097225A - Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide - Google Patents

Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide Download PDF

Info

Publication number
JP2005097225A
JP2005097225A JP2003371270A JP2003371270A JP2005097225A JP 2005097225 A JP2005097225 A JP 2005097225A JP 2003371270 A JP2003371270 A JP 2003371270A JP 2003371270 A JP2003371270 A JP 2003371270A JP 2005097225 A JP2005097225 A JP 2005097225A
Authority
JP
Japan
Prior art keywords
chlorine dioxide
livestock
uteritis
activated
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003371270A
Other languages
Japanese (ja)
Inventor
Tadashi Sukegawa
征 助川
Seiji Matsui
清治 松居
Terumi Matsui
照美 松居
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUKEGAWA CHEMICAL CO Ltd
Original Assignee
SUKEGAWA CHEMICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUKEGAWA CHEMICAL CO Ltd filed Critical SUKEGAWA CHEMICAL CO Ltd
Priority to JP2003371270A priority Critical patent/JP2005097225A/en
Publication of JP2005097225A publication Critical patent/JP2005097225A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a washing method having high bactericidal and disinfecting effect by eliminating bacteria in the uterus of livestock affected with endometritis or disinfecting the interior of uterus of the livestock. <P>SOLUTION: The method for efficiently eliminating a phlogogenic microorganism comprises washing the interior of uterus of livestock affected with uteritis by using a chlorine dioxide agent containing activated chlorine dioxide. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

発明の詳細な説明Detailed Description of the Invention

本発明は、活性化二酸化塩素による家畜の子宮炎の予防・治療に関する。
ここでいう家畜とは、有蹄類すなわちウマ、ウシ、ヒツジ、ヤギ等を包含し、その家畜の子宮内に安定および活性化された二酸化塩素を直接あるいは薬理学的に許容された担体と併用により注入し、子宮炎起炎菌の殺菌・除菌とそれらに随伴する腐敗性滲出物の消毒による子宮炎の治療・予防を特徴とする。
なお、本明細書で開示する殺菌・除菌には「滅菌」・「消毒」などの概念をも包含する。
The present invention relates to prevention and treatment of domestic animal uteritis by activated chlorine dioxide.
Livestock as used herein includes ungulates, such as horses, cows, sheep, goats, etc., and chlorine dioxide stabilized and activated in the uterus of the livestock is used directly or in combination with a pharmacologically acceptable carrier. It is characterized by the treatment and prevention of uterine inflammation by sterilization and sterilization of U. pneumoniae bacteria and disinfection of septic exudates associated therewith.
The sterilization and sterilization disclosed in this specification includes concepts such as “sterilization” and “disinfection”.

子宮炎は粘膜から筋層に炎症性変化が及ぶ場合を指し、したがってその炎症の主座する部位により子宮内膜炎、子宮筋炎、子宮周囲炎に区別される。またこの炎症性変化は漿膜に達することがあり、多くの場合、敗血症に移行することより、敗血症子宮炎と呼ばれることがある。Uteritis refers to a case where an inflammatory change extends from the mucous membrane to the muscle layer, and is therefore classified into endometritis, uterine myositis, and periuteritis depending on the site of inflammation. This inflammatory change can also reach the serosa and is often referred to as septic uteritis due to the transition to sepsis.

この敗血症性子宮炎の主因が、ブドウ球菌、連鎖球菌、大腸菌、CitrobacterやKlebsiella等腸内細菌科に属する細菌等で産期感染で発症する。The main cause of this septic endometriosis is born by infection during the period of birth with bacteria belonging to the family Enterobacteriaceae such as staphylococci, streptococci, Escherichia coli, Citrobacter and Klebsiella.

起炎菌により感染した子宮粘膜は壊死状態となり、粘膜は剥離し、膣内に壊死産物を含む腐敗性滲出物が排出する。筋層も水腫性で子宮壁全体に顆粒提出球浸潤があり、子宮静脈の炎症血栓の変化が見られる。The uterine mucosa infected by the causative fungus becomes necrotic, the mucosa is detached, and a septic exudate containing necrotic products is discharged into the vagina. The muscle layer is also edematous, with granule-presenting sphere infiltration throughout the uterine wall, and changes in inflammatory thrombus in the uterine vein.

本子宮内膜炎はウマ、ウシ、ブタ、めん羊、ヤギ等の家畜および犬、などに発症し、不妊や流産の主要な原因ともなる。すなわち本症に罹患すると、精子の運動性が抑制され、子宮内の上行を妨げ、また受精卵の子宮内膜への着床を阻害し、着床しても胎芽が早期に死滅したり、流産及び早産を誘発する。This endometritis occurs in horses, cattle, pigs, sheep, goats and other livestock and dogs, and is a major cause of infertility and miscarriages. That is, when suffering from this disease, sperm motility is suppressed, ascending in the uterus is prevented, implantation of fertilized eggs to the endometrium is inhibited, and even after implantation, the embryo is killed early, Inducing miscarriage and premature birth.

本病症は、子宮炎、肺炎、敗血症等の起因菌であるブドウ球菌、例えばS.aureusや、腎炎、咽頭炎の起炎菌で、子宮炎罹患ウマの腐敗性滲出液に多頻度で検出される連鎖球菌、例えばS.equi,S.agalactias,S.pyogenes,S.morbillorum、あるいは腸内細菌科に属する菌属で子宮内膜症、牛乳房炎から検出される大腸菌(E.coli),Citrobacter,Klebsiellaまたは日和見感染や敗血症、褥創の主因となるPseudomonas属菌などにより惹起する非伝染性の疾患である。特に、KlebsiellaやPseudomonasは抗生物質に対して抵抗機序の発現性が強く、過度の抗生物質の投薬は耐性菌による菌交代症の発症を伴い重篤な病症を呈する。This disease is caused by Staphylococcus, which is a causative bacterium such as uteritis, pneumonia, sepsis, etc. Streptococcus aureus, nephritis, pharyngitis, and streptococci frequently detected in septic exudates of horses with uteritis, such as S. aureus equi, S .; agalactias, S .; pyogenes, S .; E. coli, Citrobacter, Klebsiella detected from endometriosis, bovine mastitis, or Pseudomonas spp. which is a major cause of opportunistic infections, sepsis, and sores It is a non-infectious disease caused by. In particular, Klebsiella and Pseudomonas have strong expression of resistance mechanisms against antibiotics, and excessive antibiotic administration causes serious disease accompanied by the onset of bacterial substitution by resistant bacteria.

一方、監視伝染病の内、届出伝染病として指定されている馬伝染性子宮炎(Contagious Equine Metritis CEM)がある。本病症は、伝染性が強く、繁殖シリーズに流行し、牝ウマでは子宮内膜症、不妊症、流産を起こす生殖感染症である。On the other hand, there is equine infectious uteritis (Contagious Equine Metritis CEM), which is designated as a reported infectious disease. The disease is a reproductive infection that is highly contagious, prevalent in the breeding series, and causes endometriosis, infertility and miscarriage in mares.

本病症の主起因菌であるToylorella equigenitalisは、ウマの交尾、ヒトの手指、器具等により直接あるいは間接的に伝播し、2〜14時間の潜伏期間後、頸管炎、膣炎を伴った子宮内膜炎を発症する。1980年にはわが国でも競走馬産地で大流行し、生産者に大きな被害を与えた。Toyolorella equigenitalis, the main causative agent of this disease, is transmitted directly or indirectly by the mating of horses, human fingers, instruments, etc., and after an incubation period of 2 to 14 hours, intrauterine with cervicitis and vaginitis Develops meningitis. In 1980, it became a pandemic in the racehorse production area in Japan and caused serious damage to producers.

伝染病および非伝染性子宮炎予防・治療法は消毒剤による子宮及び種牡馬の生殖器の洗浄消毒、次いで抗生物質の投与による起炎菌の殺菌である。Infectious disease and non-infectious uteritis prevention and treatment methods include cleaning and disinfecting the genital organs of the uterus and stallions with an antiseptic, followed by sterilization of the causative bacteria by administration of antibiotics.

牝馬における伝染性および非伝染性の起炎菌の保菌部位は、主として陰核洞および陰核窩で、内部に蓄積された垢の中に起炎菌は棲息している。陰核窩および側陰核洞を洗浄によって蓄積された老廃物を除去し、消毒剤や抗生物質を注入し、浸透によって起炎菌を除去するのが常法手段である。Infectious and non-infectious disease-causing bacteria in mares are mainly carried by the clitoral sinus and clitoral fossa, and the bacteria are inhabited in the accumulated plaque. It is common practice to remove waste products accumulated by washing the clitoral fossa and lateral clitoral sinus, injecting disinfectants and antibiotics, and removing the causative bacteria by infiltration.

現時点では、交配時前後の軽種馬を消毒することを必須とし、微温湯下でのクロロヘキシジンや逆性石鹸などの低刺激性を常用としているが、この低刺激性の消毒剤ですら、陰茎の頻回消毒は粘膜の爛れが発症する。At present, it is essential to disinfect light horses before and after mating, and hypoallergenic properties such as chlorohexidine and reverse soap under mild hot water are regularly used. Even this hypoallergenic disinfectant, Round disinfection causes mucosal itch.

また、クロロヘキシジンはロータウィルス、ヘルペスウィルス、アデノウィルスには全く効果を示さず、逆性石鹸はグラム陰性および芽胞菌およびウィルスに対して有効性を示さない。
今、ウマの生殖器に対する無ないしは低刺激で、ウィルスを含めた殺菌スペクトラム広域の薬剤が種馬業者にとって切望されている。
Also, chlorohexidine has no effect on rotavirus, herpes virus, adenovirus, and reverse soap does not show efficacy against gram-negative and spore bacteria and viruses.
Currently, stallions are eagerly aspiring for drugs with a broad bactericidal spectrum, including viruses, with no or low irritation to equine genitals.

上述の子宮内洗浄は、まず38℃〜40℃に加温した滅菌生理食塩水やリンゲル液を大量に注入し、潅流(irrigation)を繰り返して子宮内を洗浄する。注入薬剤として抗生物質及び消毒剤として前記記載薬剤の他ヨード剤が一般的に使用されているのが現状である。In the intrauterine cleaning described above, first, a large amount of sterile physiological saline or Ringer's solution heated to 38 ° C. to 40 ° C. is injected, and irrigation is repeated to wash the uterus. Currently, antibiotics are generally used as injecting drugs, and iodine drugs in addition to the above-mentioned drugs are used as disinfectants.

抗生物質として一般的に使用されるクロラムフェニコールの頻回投与は骨髄抑制症候群の発症、既往免疫反応の抑制やまた急速静注により虚脱、溶血等の報告があり、また皮下及び筋注での4日以上の連用の禁止規制がとられている。またアミノグルコシド抗生物質(例えばゲンタマイシン)あるいはベータラクタム系抗生物質、キノロン系抗菌剤も副作用あるいは耐性菌の出現で頻回使用が規制されている。Frequent administration of chloramphenicol, which is commonly used as an antibiotic, has been reported to cause myelosuppression syndrome, suppression of previous immune response, and collapse and hemolysis due to rapid intravenous injection. The prohibition of continuous use for more than 4 days is taken. Aminoglucoside antibiotics (for example, gentamicin), beta-lactam antibiotics, and quinolone antibacterial agents are also regulated for frequent use due to the appearance of side effects or resistant bacteria.

一方、消毒剤による子宮内局所消毒は、その有効性と毒性との兼ね合いから消毒剤の選択を考えねばならない。すなわち、消毒対象物の清潔要求度、生体消毒と環境消毒、pH、作用時間、温度、濃度等の基本条件、消毒スペクトラムの範囲、消毒剤が生体に与える毒性、作用の持続性、吸収性と浸透性、有機物共存下での有効性、耐性菌の出現性、臭気及び色素の沈着性、使用方法の簡易性、排気処理方法の容易性等から選択しなければならない。On the other hand, in the local sterilization with a disinfectant, selection of a disinfectant must be considered in view of its effectiveness and toxicity. That is, the cleanliness requirement of the object to be disinfected, biological disinfection and environmental disinfection, basic conditions such as pH, action time, temperature, concentration, range of disinfection spectrum, toxicity of disinfectant to living body, sustainability of action, absorbability It must be selected based on permeability, effectiveness in the presence of organic substances, emergence of resistant bacteria, odor and pigment deposition, ease of use, and ease of exhaust treatment.

現在広く使用されている子宮洗浄消毒剤として消毒スペクトラムの広さからヨード剤、特にポピドンヨードが使用されている。一般にヨード剤は手指への消毒に用いられているが、腐食性が強く、下痢、下血、呼吸困難、頭痛などの副作用症状を呈し、環境一般金属器具、排出物による汚染物の消毒には不向きとされている。本薬剤を膣や口腔粘膜、熱傷部位及び新生児の正常な皮膚に対する皮膚炎の発症が報告されている。As a uterine washing disinfectant that is widely used at present, iodine agents, especially popidone iodine, are used because of the wide disinfection spectrum. In general, iodine is used for disinfection of fingers, but it is highly corrosive and has side effects such as diarrhea, diarrhea, dyspnea, and headache. It is considered unsuitable. Onset of dermatitis to the vagina, oral mucosa, burn site and normal skin of newborns has been reported with this drug.

ポピドンヨードの最小致死細菌濃度は大腸菌に対して10ppm以上、黒コウジカビに対しては1000ppmであり、二酸化塩素はこの細菌力より10〜100倍も強烈な殺菌力(日本食品分析センター、1995年)を示し、しかも皮膚毒性が著しく低いとされている活性化二酸化塩素による子宮内洗浄除菌法について鋭意検討を行った。The minimum lethal bacterial concentration of popidone iodine is 10 ppm or more for Escherichia coli and 1000 ppm for Aspergillus niger, and chlorine dioxide has a bactericidal power 10-100 times stronger than this bacterial power (Japan Food Analysis Center, 1995). In addition, intensive studies were carried out on the sterilization method of uterine lavage using activated chlorine dioxide, which was shown to have extremely low skin toxicity.

活性化二酸化塩素による家畜の子宮洗浄については今まで開示された事例はない。しかも二酸化塩素は、その殺菌力の強さにも拘わらず、一般に反応が遅効性であるがため、消毒剤としては不向きで、むしろ消臭向きと従来考えられてきた。発明者らは二酸化塩素が有する遅効性という特性を改善し、即効的に作用を発現するように工夫を重ね、今までに報告事例がない活性化二酸化塩素による家畜の子宮洗浄剤の検討を重ねてきた。There has been no case disclosed to date of uterine lavage of livestock with activated chlorine dioxide. In addition, chlorine dioxide has been conventionally considered to be unsuitable as a disinfectant, but rather deodorant, because the reaction is generally slow-acting in spite of its strong bactericidal power. The inventors have improved the slow-acting properties of chlorine dioxide and devised it to produce immediate action, and have repeatedly studied livestock uterine cleansing agents using activated chlorine dioxide that have never been reported. I came.

活性化二酸化塩素は次亜塩素酸ソーダと異なり、血清蛋白あるいは他の有機物と反応して発癌性を有するトリハロメタン等の化合物を生成せず、またその作用はpHの影響を受けず、広いpH値域で有効性を発揮する。Activated chlorine dioxide, unlike sodium hypochlorite, does not produce carcinogenic compounds such as trihalomethanes by reacting with serum proteins or other organic substances, and its action is not affected by pH and has a wide pH range. To demonstrate effectiveness.

活性化二酸化塩素のヒトの皮膚に対する刺激性試験を検討したところ、高濃度一週間累積貼付で全く刺激性が認められず、実投与濃度でも子宮粘膜に対して何ら影響を示さない事を認めた。Examination of the irritancy test of activated chlorine dioxide on human skin revealed no irritation at high concentration for one week, and no effect on the uterine mucosa even at the actual administration concentration. .

発明が解決しようとする課題Problems to be solved by the invention

かかる点を考慮して活性化二酸化塩素による家畜、特に軽種馬の子宮炎の予防・治療について鋭意検討を重ねてきた。
本発明である活性化二酸化塩素は、濃度管理を施す事によりヒトの皮膚や軽種馬の子宮膜に対して殆ど副作用を認めず、子宮起炎菌の二酸化塩素に対する耐性獲得もなく、しかも高蛋白下で、細菌・カビあるいはウイルスに対しても殺菌・消毒効力を示す。このような特性を踏まえ、活性化二酸化塩素を軽種馬子宮内に注入する治験を試みた。
Considering this point, we have made extensive studies on the prevention and treatment of livestock, especially light stallion, with activated chlorine dioxide.
The activated chlorine dioxide of the present invention has almost no side effects on human skin or light horse endometrium due to concentration control, has no acquired resistance to chlorophyll of U. pneumoniae, and has a high protein content. Below, it shows bactericidal and disinfecting effects against bacteria, molds and viruses. Based on these characteristics, a trial was conducted in which activated chlorine dioxide was injected into the bred horse uterus.

二酸化塩素の除菌・殺菌効力は、有機酸、鉱物酸、過酸化水素、アルコール類及びこれらを併用した賦活剤(例えば助川化学(株)製MEシリーズ)から選択した化合物によりpH3.5〜7.0、より好ましくはpH4.0〜6.5に調製して二酸化塩素を活性する事が出来る。The disinfection and bactericidal efficacy of chlorine dioxide is pH 3.5-7 depending on the compound selected from organic acids, mineral acids, hydrogen peroxide, alcohols and activators using these in combination (for example, ME series manufactured by Sukegawa Chemical Co., Ltd.). It is possible to activate chlorine dioxide by adjusting to pH 4.0, more preferably pH 4.0 to 6.5.

課題を解決するための手段Means for solving the problem

濃度管理を施された活性化二酸化塩素はヒトの皮膚に対して1000ppm、一週間の累積貼布で殆ど影響を認めない事、目の粘膜に対して刺激性が非常に弱い事、微生物に対して広い殺菌毒域を示す事、広いpH範囲で活性が発現する事、高蛋白下でも活性を示す事、発癌性であるトリハロメタンの生成を認めない事、また塩素ガスの発生や有機物と結合して異臭を発生しない事など活性化二酸化塩素が有する優れた特性に注目し、鋭意検討を重ねた結果、家畜生産者にとって生産性を著しく阻害する子宮炎の治療・予防のための活性化二酸化塩素を子宮洗浄薬剤使用に初めて成功した。Concentration-controlled activated chlorine dioxide is 1000 ppm for human skin, has little effect on cumulative pasting for one week, is very irritating to the mucous membrane of the eye, is resistant to microorganisms It exhibits a wide range of bactericidal poisons, exhibits activity over a wide pH range, exhibits activity even under high proteins, does not allow the formation of carcinogenic trihalomethanes, generates chlorine gas, and binds to organic substances. Focusing on the excellent properties of activated chlorine dioxide, such as the fact that it does not generate off-flavors, and as a result of intensive studies, activated chlorine dioxide for the treatment and prevention of uteritis that significantly impairs productivity for livestock producers The first successful use of uterine irrigation drugs.

発明実施の形態Embodiment of the Invention

本願明細書における活性化二酸化塩素とは二酸化塩素を含有する物を言い、例えば亜塩素酸ナトリウム、亜塩素酸カリウム等の亜塩素酸に塩酸、硫酸などの無機酸を加えることにより発生させることができる。The activated chlorine dioxide in the present specification refers to a substance containing chlorine dioxide, which can be generated by adding an inorganic acid such as hydrochloric acid or sulfuric acid to chlorous acid such as sodium chlorite and potassium chlorite. it can.

また、上記二酸化塩素は、亜塩素酸塩を安定化剤により安定化させた安定化二酸化塩素剤から発生させてもよい。ここで安定化剤としてNaCO・3HO、NaHCO、NaBO等を挙げる事ができる。The chlorine dioxide may be generated from a stabilized chlorine dioxide agent obtained by stabilizing chlorite with a stabilizer. Here, examples of the stabilizer include NaCO 3 .3H 2 O, NaHCO 3 , and NaBO 3 .

更に、上記活性化二酸化塩素は、上記二酸化塩素剤を有機酸、無機酸、過酸化水素およびアルコール類から選択される活性化剤により二酸化塩素を発生させてもよい。ここでいう有機酸類として、例えばクエン酸、酢酸などを代表例として挙げる事ができる。 また上記アルコール類としてエタノール、メタノールを挙げる事ができる・Furthermore, the activated chlorine dioxide may generate chlorine dioxide by an activating agent selected from organic acids, inorganic acids, hydrogen peroxide and alcohols. Typical examples of organic acids here include citric acid and acetic acid. Examples of the alcohols include ethanol and methanol.

上記活性化二酸化塩素の一般細菌、大腸菌群(Coliform bacteria),黄色ブドウ球菌(Staphylococcus aureus),A群連鎖球菌(Group AStreptococcus)に対する除菌・殺菌効果を高めるためpHを7.0以下、より好ましくはpH5.5〜6.5に調整する。In order to enhance the disinfection and bactericidal effect of the activated chlorine dioxide on general bacteria, coliform bacteria, Staphylococcus aureus, and group A streptococcus, the pH is preferably 7.0 or less. Is adjusted to pH 5.5-6.5.

本発明において、活性化二酸化塩素濃度は0.1〜100ppmであり、より好ましい濃度は10〜75ppmで、さらに好ましくは25〜50ppmである。In the present invention, the activated chlorine dioxide concentration is 0.1 to 100 ppm, more preferably 10 to 75 ppm, and further preferably 25 to 50 ppm.

活性化二酸化塩素の除菌・殺菌機序は微生物の生育に関わる重要な代謝関連酵素および細胞膜組成中のチロシン、メチオニンおよびシスチン残基を特異的に酸化させ、その機能を不活化させる事により微生物を崩壊あるいは死滅させるものである。 この酸化能はオゾンより特異的で、そのため非常に優れた殺菌・除菌をもたらす。従って、それによる副作用が著しく弱い所以である。また、耐性菌の出現は殆ど見られない。 二酸化塩素は次亜塩素酸ナトリウムと異なり、有機物との結合が比較的緩慢なため、高蛋白下でもその効力を長時間保持する。The sterilization and sterilization mechanism of activated chlorine dioxide is an important metabolic-related enzyme involved in the growth of microorganisms and tyrosine, methionine and cystine residues in the cell membrane composition are specifically oxidized to inactivate their functions. Is to collapse or kill. This oxidizing ability is more specific than ozone, and therefore provides excellent sterilization and sterilization. Therefore, the side effects caused thereby are extremely weak. Moreover, the appearance of resistant bacteria is hardly seen. Chlorine dioxide, unlike sodium hypochlorite, has a relatively slow binding with organic substances, and therefore retains its efficacy for a long time even under high protein.

本発明での活性化二酸化塩素による家畜の子宮内洗浄除菌方法は、ゴム製、プラスチックせいあるいは金属製の管状の器具(子宮洗浄嘴管)を子宮内に注意深く挿入する。この子宮洗浄嘴管は子宮および子宮頸などそれぞれの副生殖器の構造に合わせて使いやすく損傷を与えないよう工夫したもであれば良い。
更に、洗浄終了後薬剤が注入できるよう接続部を装着してもよい。
このように注入法は、自己製作品あるいは市販品に限定する物ではない。
また、注入法は落差注入あるいは電動注入でもよく、注入手段にとらわれるものではない。
In the method for sterilizing livestock in the uterus using activated chlorine dioxide according to the present invention, a rubber, plastic or metal tubular instrument (uterine lavage tube) is carefully inserted into the uterus. This uterine lavage tube can be used in accordance with the structure of each accessory genital organ such as the uterus and cervix so as not to be damaged.
Further, a connecting portion may be attached so that the medicine can be injected after the cleaning is completed.
Thus, the injection method is not limited to self-made works or commercial products.
The injection method may be drop injection or electric injection, and is not limited to the injection means.

治療を目的とした洗浄時期は、産褥期感染時、種付後数時間後、腐敗性滲出時、子宮静脈の炎症性血栓異常診断時の微生物罹患部分内に注入洗浄消毒を行う。The cleaning period for treatment is injection, cleaning and disinfection in the part affected by microorganisms at the time of puerperal infection, several hours after seeding, septic exudation, and diagnosing inflammatory thrombus abnormality of uterine vein.

発明の実施形態Embodiment of the Invention

以下の具体的な実験例、実施例によって本発明を更に具体的に説明するが、本発明はこれによって限定されるものではない。The present invention will be described more specifically by the following specific experimental examples and examples, but the present invention is not limited thereto.

実験例1Experimental example 1

各微生物に対する活性化二酸化塩素の殺菌効力結果を表 1に示す。この際の反応条件は反応時間5分、25℃である。
ウマ子宮炎の主要起炎菌であり、また子宮滲出液中からも多頻度によ検出される黄色ブドウ球菌、連鎖球菌、大腸菌および大腸菌群に包含されるCitrobacter、Klebsiellaはすべて5分間の反応で完全に死滅する。
各微生物に対する活性化二酸化塩素の殺菌効力を表1に示す。
Table 1 shows the results of the bactericidal efficacy of activated chlorine dioxide for each microorganism. The reaction conditions in this case are a reaction time of 5 minutes and 25 ° C.
Citrobacter and Klebsiella included in Staphylococcus aureus, Streptococcus, Escherichia coli and Escherichia coli, which are major infectious agents of equine uteritis and are frequently detected in uterine exudates, are all reacted in 5 minutes. Completely killed.
Table 1 shows the bactericidal efficacy of the activated chlorine dioxide for each microorganism.

Figure 2005097225
血清蛋白共存下での軽種馬子宮炎主要起炎菌に対する活性化二酸化塩素殺菌力について
Figure 2005097225
Activated chlorine dioxide bactericidal activity against major causative bacteria of light horse equine uteritis in the presence of serum proteins

に記載する。It describes.

実験例2Experimental example 2

黄色ブドウ球菌(S.aureus),A群連鎖球菌(GroupA Streptococcus)および大腸菌(E.coli)に対する牛血清アルブミン(BSA 0.5% 和光薬品株式会社)共存下での活性化二酸化塩素の殺菌効力試験結果を表2に示す。Bactericidal efficacy of activated chlorine dioxide in the presence of bovine serum albumin (BSA 0.5% Wako Pharmaceutical Co., Ltd.) against S. aureus, Group A Streptococcus and E. coli The test results are shown in Table 2.

Figure 2005097225
この表が示すように、BSAの共存下での活性化二酸化塩素はBSAフリーの場合とほぼ同じ活性を示す。 即ち、活性化二酸化塩素は、次亜塩素酸ナトリウムと異なり共存する蛋白と結合することなく、子宮内でも試験管レベル(in vivo)と同じ除菌・殺菌活性が生体内(in vivo)でも発現する事を示唆している。
Figure 2005097225
As this table shows, activated chlorine dioxide in the presence of BSA shows almost the same activity as in the case of BSA free. That is, activated chlorine dioxide does not bind to coexisting protein unlike sodium hypochlorite, and the same sterilization and bactericidal activity as in vitro is expressed in vivo as well as in vivo. Suggests to do.

実験例3Experimental example 3

活性化二酸化塩素のヒト皮膚に対する安全性試験を川村の方法(川村太郎貼布試験標準化の基礎的研究80 301 1970)に準拠して実施した。
貼布条件は、単回および1周間の連続貼布(累積貼布試験)であり、皮膚表面の変化は肉視観察し、上記文献記載の基準により評価した。実験方法として単回および累積貼布試験ではヒト上腕内側にパッチテスト用絆創膏(1.5x1.5cm)に陰性対照としての水、被検体として活性化二酸化塩素200ppm、500ppmおよび1000ppm各々100μlをしみ込ませ、単回試験での皮膚との接触時間を24時間閉塞貼付し、累積貼付では24時間閉塞貼付を1週間連続繰り返した。評価判定は絆創膏除去後、30分静置して肉視観察した。
単回貼布刺激結果を表3に示す。
A safety test of activated chlorine dioxide on human skin was carried out in accordance with the method of Kawamura (Taro Kawamura standardization test for standardization of the patch test 80 301 1970).
The application condition was single and continuous application for one round (cumulative application test), and changes in the skin surface were visually observed and evaluated according to the criteria described in the above literature. As an experimental method, in the single and cumulative patch test, patch adhesive bandage (1.5 x 1.5 cm) is impregnated inside the human upper arm with water as a negative control, and activated chlorine dioxide 200 ppm, 500 ppm and 1000 ppm each as 100 μl as a subject. In the single test, the contact time with the skin was occluded for 24 hours, and in the cumulative application, the occlusion for 24 hours was repeated continuously for 1 week. The evaluation was determined by standing for 30 minutes after removing the adhesive bandage and visually observing.
Table 3 shows the results of single-ply stimulation.

Figure 2005097225
活性化二酸化塩素累積貼布によるヒト皮膚の刺激試験結果については
Figure 2005097225
About result of irritation test of human skin by activated chlorine dioxide cumulative patch

で記述する。Describe in.

Figure 2005097225
Figure 2005097225

この際の評価判定基準を表5に示す。

Figure 2005097225
この結果、活性化二酸化塩素の実使用濃度の10〜20倍の濃度で1〜7日間の単回および累積貼付で全くヒトの皮膚に対して刺激性は認められなかった。Table 5 shows the evaluation criteria at this time.
Figure 2005097225
As a result, no irritation was observed on human skin at single to cumulative application for 1 to 7 days at a concentration of 10 to 20 times the actual use concentration of activated chlorine dioxide.

子宮内の滲出液が間歇的に会陰部から漏出した子宮内膜炎を発症および早期発情を繰り返す牝馬13頭に対して子宮洗浄嘴管を挿入し、子宮内視鏡で観察しながら、加温滅菌生理食塩水100〜200mlを子宮内に注入し、直腸から子宮角及び子宮体を軽く圧して回収し、その回収液を処理前検液として肉視および 顕微鏡で観察した。 次いで、活性化二酸化塩素(Biosukegawa design #1000)を滅菌生理食塩水で50〜1000ppm、1〜18Lを調整した後、イルリガートルに充填し、子宮内視鏡と子宮洗浄嘴管を用いて38℃〜40℃に保温しながら子宮内に注入した。1〜2日間放置後、同量の生理食塩水で1〜2回洗浄し、その洗浄液について微生物の検出を行った。対照検出微生物は子宮内膜炎の主起炎菌であるE.Coli、Streptococcus,Klebsiella,Citrobacter Pseudomonas及びStaphylococcusの検出を行った。検出菌の分類同定は常法に従った。その結果を表6に示す。なお、効果判定は対象起菌炎菌の消失結果と滲出液外観より求め、その治療効果につてはUterine lavage ducts were inserted into 13 mares that developed endometriosis where exudate in the uterus leaked intermittently from the perineum and repeated early estrus, and warmed while observing with a uteroscope 100 to 200 ml of sterilized physiological saline was injected into the uterus, and the uterine horn and uterine body were lightly pressed and collected from the rectum, and the collected solution was macroscopically and observed with a microscope as a pre-treatment test solution. Next, activated chlorine dioxide (Biosukegawa design # 1000) was adjusted to 50 to 1000 ppm and 1 to 18 L with sterilized physiological saline, and then filled into an irrigator, followed by using a uterine endoscope and a uterine lavage tube. The sample was injected into the uterus while being kept at 40 ° C. After being left for 1-2 days, it was washed once or twice with the same amount of physiological saline, and microorganisms were detected in the washing solution. The control detection microorganism is E. coli which is the main causative bacterium of endometritis. Detection of Coli, Streptococcus, Klebsiella, Citrobacter Pseudomonas and Staphylococcus was performed. The classification and identification of the detected bacteria followed a conventional method. The results are shown in Table 6. In addition, the effect judgment is obtained from the disappearance result of the target bacilli and the exudate appearance.

に纏めた。I summarized it.

Figure 2005097225
Figure 2005097225
Figure 2005097225
Figure 2005097225

表6Table 6

に示した活性化二酸化塩素の除菌・殺菌洗浄による軽種馬子宮内膜炎の治療効果を表7に示す。Table 7 shows the therapeutic effect of light horse endometritis by sterilization and sterilization washing of activated chlorine dioxide shown in Table 7.

Figure 2005097225
有効率76.9%と高い示し、活性化二酸化塩素の馬子宮洗浄・除菌の有効性が認められた。
Figure 2005097225
The effectiveness rate was as high as 76.9%, and the effectiveness of cleaning and sanitizing equine uterus with activated chlorine dioxide was confirmed.

参考例1Reference example 1

活性化二酸化塩素でウマ子宮炎の洗浄・除菌を行なった際の活性化二酸化塩素によるウマ子宮内膜に対する刺激性の診断した結果を表8に示す。Table 8 shows the results of diagnosis of irritation to the horse endometrium by activated chlorine dioxide when equine uteritis was washed and sterilized with activated chlorine dioxide.

Figure 2005097225
Figure 2005097225
この結果、活性化二酸化塩素1〜10ppm濃度、18Lで子宮内を洗浄しても子宮内膜に何ら影響を与えないことを認めた。
この結果、活性化二酸化塩素1〜10ppm濃度、18Lで子宮を洗浄しても子宮内膜に何ら影響を与えず、安全性が高い薬剤であることを認めた。
Figure 2005097225
Figure 2005097225
As a result, it was confirmed that even if the uterus was washed with 18 L of activated chlorine dioxide at a concentration of 1 to 10 ppm, the endometrium was not affected.
As a result, it was confirmed that even if the uterus was washed with activated chlorine dioxide at a concentration of 1 to 10 ppm and 18 L, the endometrium was not affected and the drug was highly safe.

発明の効果The invention's effect

以上説明したように、病原微生物に感染した馬子宮内膜を活性化二酸化塩素で洗浄除菌する事により、病症の改善を指標として76.9%という有効率が示された。すなわち活性化二酸素の洗浄により馬子宮内膜炎の治療および予防が可能であることが示唆された。また、子宮洗浄に際し、活性化二酸化塩素による子宮内膜の紅斑、丘疹、浮腫、水泡等の副作用の発症症例は見られず、非常に安全で有効な洗浄・治療剤であることを確認した。
更に、家畜生産者の致命的な損害をもたらす監視伝染病に含まれている馬伝染性子宮炎(CEM)に対しても効果的な感染治予防・療剤として曙光を意味するものである。
これにより、活性化二酸化塩素は軽種馬子宮炎の予防・治療にかかわらず、牛、豚等の家畜全般の子宮炎の予防・治療が可能となり、ひいては稀少動物の人工受精の際、殺菌・消毒剤として使用可能である。
As described above, by cleaning and sterilizing horse endometrium infected with pathogenic microorganisms with activated chlorine dioxide, an effective rate of 76.9% was shown using disease improvement as an index. In other words, it was suggested that washing and activating dioxygen can be used to treat and prevent equine endometritis. In addition, upon uterine lavage, no side effects such as erythema, papules, edema and blisters of the endometrium caused by activated chlorine dioxide were observed, and it was confirmed that this was a very safe and effective washing and treating agent.
Furthermore, it also means fluorescence as an effective treatment for preventing and treating equine infectious uteritis (CEM), which is included in surveillance infectious diseases that cause fatal damage to livestock producers.
As a result, activated chlorine dioxide enables prevention and treatment of all types of cattle, swine and other livestock, regardless of prevention and treatment of light horse equine uteritis. As a result, sterilization and disinfection during artificial insemination of rare animals It can be used as an agent.

Claims (9)

活性化二酸化塩素並びに二酸化塩素剤を主成分とする家畜子宮炎の予防・治療剤。A preventive / treating agent for livestock uteritis, mainly composed of activated chlorine dioxide and chlorine dioxide. 活性化二酸化塩素並びに二酸化塩素を含有する水溶液であって、pH7.0以下、好ましくはpH6.0で使用することを特徴とする家畜子宮炎の予防・治療剤。An aqueous solution containing activated chlorine dioxide and chlorine dioxide, which is used at pH 7.0 or lower, preferably pH 6.0, for preventing and treating livestock uteritis. 活性化二酸化塩素並びに薬理学的に許容される担体の併用による家畜の子宮内に直接注入することを特徴とする家畜子宮炎の治療・予防法。A method for the treatment and prevention of veterinary uteritis characterized by direct injection into the uterus of livestock using a combination of activated chlorine dioxide and a pharmacologically acceptable carrier. 前記二酸化塩素並びに二酸化塩素剤は、溶存二酸化塩素ガス水溶液、亜塩素酸及びその塩を含有することを特徴とする請求項1〜3に記載する家畜子宮炎の治療・予防剤。The said chlorine dioxide and chlorine dioxide agent contain the dissolved chlorine dioxide gas aqueous solution, chlorous acid, and its salt, The treatment / prevention agent of livestock uteritis of Claims 1-3 characterized by the above-mentioned. 前記二酸化塩素並びに二酸化塩素は、安定化剤により安定化された安定化二酸化塩素から発生することを特徴とする請求項1〜3に記載する家畜子宮炎治療・予防剤。4. The livestock uteritis treatment / prevention agent according to claim 1, wherein the chlorine dioxide and chlorine dioxide are generated from stabilized chlorine dioxide stabilized by a stabilizer. 前記活性化二酸化塩素は、前記二酸化塩素剤を有機酸類、鉱物酸類及び過酸化水素及びアルコール類から選択される賦活剤により、二酸化塩素の発生を活性化した二酸化塩素剤から発生することを特徴とする家畜子宮炎の治療・予防剤。The activated chlorine dioxide is generated from a chlorine dioxide agent which has activated the generation of chlorine dioxide by an activator selected from organic acids, mineral acids, hydrogen peroxide and alcohols. A therapeutic / preventive agent for livestock uterine inflammation. 前記二酸化塩素剤における前記二酸化塩素の使用濃度は、0.1〜500ppmである請求項1〜6のいずれかに記載する家畜子宮炎の治療・予防剤。The use / concentration of the chlorine dioxide in the chlorine dioxide agent is 0.1 to 500 ppm. 前記活性化二酸化塩素を子宮洗浄嘴管を通し子宮内に注入し、子宮内微生物感染疾患部の消毒により疾患患部の治療を特徴とする子宮炎治療・予防法。A method for treating and preventing uterine inflammation characterized by injecting the activated chlorine dioxide into a uterus through a uterine lavage fistula and treating the diseased part by disinfection of the diseased part of the uterine microorganism. 前記家畜は、軽種馬である請求項1〜7のいずれかに記載する子宮炎の治療・予防剤。The said domestic animal is a light stallion, The therapeutic / preventive agent of the uteritis in any one of Claims 1-7.
JP2003371270A 2003-09-24 2003-09-24 Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide Pending JP2005097225A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003371270A JP2005097225A (en) 2003-09-24 2003-09-24 Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003371270A JP2005097225A (en) 2003-09-24 2003-09-24 Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide

Publications (1)

Publication Number Publication Date
JP2005097225A true JP2005097225A (en) 2005-04-14

Family

ID=34463726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003371270A Pending JP2005097225A (en) 2003-09-24 2003-09-24 Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide

Country Status (1)

Country Link
JP (1) JP2005097225A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103040860A (en) * 2012-11-29 2013-04-17 刘学武 Method for initiating mammalian stem cells and application of chlorine dioxide in preparation of medicament for initiating mammalian stem cells
US11534951B2 (en) 2017-06-13 2022-12-27 The Japan Steel Works, Ltd. Apparatus, method and computer program product for screw configuration inference

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103040860A (en) * 2012-11-29 2013-04-17 刘学武 Method for initiating mammalian stem cells and application of chlorine dioxide in preparation of medicament for initiating mammalian stem cells
US11534951B2 (en) 2017-06-13 2022-12-27 The Japan Steel Works, Ltd. Apparatus, method and computer program product for screw configuration inference

Similar Documents

Publication Publication Date Title
Hübner et al. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds
EP1740166B1 (en) Therapeutic antimicrobial compositions and methods
JP4670107B2 (en) Infectious skin and mucosal disease treatment
WO2007100917A2 (en) Antimicrobials and related methods
US7097861B1 (en) Method of treating livestock footbath solutions
Boothe Antiseptics and disinfectants
US9107418B2 (en) Animal lesion treatment and prevention formulations and methods
JP2556973B2 (en) Antiseptic composition
JP2015535298A (en) Powder composition for disinfection of dairy nipples
Sadiq et al. Pharmaceutical Importance of Anti-Microbials
CN104224824A (en) Iodine disinfection solution for preventing and treating freshwater biological virus erosion
JP2005097225A (en) Prophylaxis and treatment of livestock uteritis by activated chlorine dioxide
CN101972271B (en) Chlorine dioxide mucous membrane gel and preparation method thereof
WO2022075888A1 (en) Aqueous anti-bacterial composition for treating infectious diseases of the hoof
KR100218093B1 (en) Germicide composition from yucca extract for animal
CN113082050A (en) Temperature-sensitive gel for gynecology and preparation method thereof
Jacob Antiseptics and Disinfectants
JP2004313156A (en) Treatment of mastitis of stock by activated chlorine dioxide
JP2020502249A (en) Compositions and methods comprising acetic acid and hypochlorous acid for treating biofilms
RU2228185C1 (en) Method for treating cows in case of afterbirth retention
RU2181595C2 (en) Method to treat acute endometritis in cows
RU2668377C1 (en) Disinfectant for premise treatment
RU2660579C1 (en) Method for treating postnatal pus-catarrhal endometritis in cows
Gupta et al. Gross, histopathological, microbiological and management studies of pyometra in bitches.
KR20050088968A (en) Disinfectant for cattles

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Effective date: 20050829

Free format text: JAPANESE INTERMEDIATE CODE: A7422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071204

A02 Decision of refusal

Effective date: 20080513

Free format text: JAPANESE INTERMEDIATE CODE: A02